FindTrial
Sign In

Effect of concomitant use of Clopidogrel with Ilaprazole

Pharmacodynamic evaluation of Clopidogrel coadministered with Ilaprazole - An Open-label Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067704
Enrollment
60
Registered
2024-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I248- Other forms of acute ischemic heart disease Health Condition 2: I52- Other heart disorders in diseasesclassified elsewhere

Interventions

Intervention1: Group 2: Clopidogrel (75 mg) + Ilaprazole (10 mg) in 30 patients for duration of 21 days Control Intervention1: Group 1: Clopidogrel (75 mg) + Pantoprazole (40 mg) in 30 patients for

Sponsors

SRM College of Pharmacy, SRM Institute of Science and Technology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient diagnosed with Acute coronary syndrome and willing to give informed consent form

Exclusion criteria

Exclusion criteria: Concomitant drugs that affects CYP2C19 metabolism Pregnancy/ Lactating women Patient with liver disease Patient with pscyhiatric disorders

Design outcomes

Primary

MeasureTime frame
Monitoring of Platelet Reactivity IndexTimepoint: From Baseline,7th,14th and 21st day—

Secondary

MeasureTime frame
1. Monitoring complete blood count parameters of the study enrolled participants 2. Monitoring of any adverse events during the studyTimepoint: From Baseline,7th,14th and 21st day—

Countries

India

Contacts

Public ContactDr Damodharan N

SRM College of Pharmacy, SRM Institute of Science and Technology

damodhan@srmist.edu.in9443591925

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026